Tandem use of antiplatelets and anticoagulants is common, the authors noted, and this analysis suggests the relative risk of bleeding is similar for dabigatran and warfarin.
In patients with atrial fibrillation, the advantages of all 4 new oral anticoagulants over warfarin seem to outweigh the risks, a new meta-analysis found. ... This meta-analysis“ support(s) the premise that compared with warfarin, new oral
Of these, 7.2% (32) involve anticoagulants; of those, twothirds (21) involve heparin. ... Clearly label syringes and other containers used for anticoagulants; and. Clarify all anticoagulant dosing for pediatric patients, who are higher risk because these
Details on anticoagulant regulation and more.
Researchers recently developed a new biomarker-based bleeding risk score for patients with atrial fibrillation (AF) to help decision making about oral anticoagulation. ... The ABC-bleeding score should therefore“ be useful as decision support regarding
The thrombotic event was unprovoked, and anticoagulation was discontinued after six months of therapy. ... Continuous effective anticoagulation is needed throughout pregnancy in women with mechanical heart valves.
Exactly which anticoagulant to use in a given circumstance, and how to use it, is always a hot topic among hospitalists. ... Read our cover story about his discussion of bleeding risks, warfarin bridging, and concomitant use of anticoagulants with drugs
Braithwaite.“ By having one team managing the majority of anticoagulation, we are beginning to reduce complications.”. ... George was instrumental in the hospital achieving nearly 100% compliance on all Joint Commission core measures and implementing
Since nearly 19% of the drug administration events in 2007-2009 involved anticoagulation therapy, the NYACP has taken steps to increase awareness of appropriate anticoagulation therapy and dosing. ... The chapter offered a one-hour training Webinar,
The convenience and reduced risks of oral anticoagulants are encouraging a shift toward initiating anticoagulation for all but the lowest-risk patients, although issues like reversibility and myocardial infarction risk remain.